Intelligence · Patents
Patents expiring in 2036
Annual patent cliff calendar for 2036 — US pharmaceutical patents by expiration date.
- Patents
- 1,428
Quick answer
1,428 indexed pharmaceutical patents have expiration dates in 2036. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 9518096
Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
granted -
US 9517067
System and method for satellite drug delivery
granted -
US 9517224
Methods of treating patients infected with HIV and HTLV
granted -
US 9522906
Tetrahydroquinoline analogues as muscarinic agonists
granted -
US 9522289
Selective fat removal using photothermal heating
granted -
US 9522156
Nitrated lipids and methods of making and using thereof
granted -
US 9522910
Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon
granted -
PT 2214636
ORAL DOSAGE FORMS COMPRISING LICARBAZEPINE ACETATE
granted -
PT 2121138
THERAPEUTICAL USES OF ESLICARBAZEPINE
granted -
US 9522179
Compositions and methods for modulating cardiac conditions
granted -
US 9522145
Modulators of ATP-binding cassette transporters
granted -
US 9522112
System, method, and kit for selecting and preparing customized cosmetics
granted -
US 9522963
Dissolution of oxidized cellulose
granted -
US 9523691
Use of the olfactomedin-4 protein (OLFM4) in colorectal cancer diagnosis
granted -
US 9523675
Insect repellent and attractants
granted -
US 9523094
Methods of treating kennedy's disease
granted -
US 9523079
Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes
granted -
US 9522948
GP100-specific T cell receptors and related materials and methods of use
granted -
US 9522871
Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failure
granted -
US 9522180
Peptide conjugated particles
granted -
US 9522241
Controlled release nanoparticulate matter delivery system
granted -
US 9523695
Therapeutic antibodies against ROR-1 protein and methods for use of same
granted -
US 9522955
Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
granted -
US 9522185
Human antibodies to GFR α3 and methods of treating pain associated with osteoarthritis or bone cancer
granted -
US 9522137
Methods for dosing an orally active 1,2,4-Oxadiazole for nonsense mutation suppression therapy
granted -
US 9521845
Beta-lactones as antibacterial agents
granted -
US 9526786
Thermostabilization of proteins
granted -
US 9526765
Delivery of therapeutic agents by a collagen binding protein
granted -
US 9526796
Peptide-based in vivo siRNA delivery system
granted -
US 9526777
Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein
granted -
US 9526803
Diagnostic chewing gum for pathogens
granted -
US 9526824
Nanochanneled device and related methods
granted -
US 9527819
Pyridazine compounds, compositions and methods
granted -
US 9527807
Sulfonamide derivative and use thereof
granted -
US 9527841
Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitors
granted -
US 9527868
ETP derivatives
granted -
US 9527878
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
granted -
US 9527919
High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection
granted -
US 9527903
Engineered antibody constant domain molecules
granted -
US 9527884
Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use
granted -
US 9526882
Percutaneous administration device and method for producing the same
granted -
US 9526769
Macrocylic oximyl hepatitis C protease inhibitors
granted -
US 9526760
LEDGF peptides and formulations thereof for treatment of degenerative disorders
granted -
US 9529005
Modulating bacterial MAM polypeptides in pathogenic disease
granted -
US 9528109
Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mRNA
granted -
US 9529001
Methods of diagnosing and treating autism
granted -
US 9526799
Low density lipoprotein receptor-mediated siRNA delivery
granted -
US 9528094
Attenuated African swine fever virus vaccine based in the deletion of MGF genes
granted
Frequently asked questions
How many pharma patents expire in 2036?
1,428 published patents in our USPTO index have expiration dates falling in calendar year 2036.